Request Demo
Last update 08 May 2025
Epoetin alfa biosimilar (United Biomedical)
Last update 08 May 2025
Overview
Basic Info
Drug Type Biosimilar, Colony-stimulating factors |
Synonyms Epoetin Alfa Biosimilar (United Biomedical, Inc.), Epoetin alfa biosimilar, rhEPO + [2] |
Target |
Action agonists |
Mechanism EPO receptor agonists(Erythropoietin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 9003
The sequence is quoted from: *****
Related
4
Clinical Trials associated with Epoetin alfa biosimilar (United Biomedical)ChiCTR2200066165
Combined rhEPO and Iron sucorse usage on Cardiac Surgery patients to reduce transfusion - CEICS randomized trial
NCT02708914
A Phase III Trial to Compare the Safety and Efficacy of Intravenous UB-851 and Eprex® With an Extension Safety Evaluation in Subjects With Renal Anemia on Hemodialysis
NL-OMON26568
Randomized controlled trial on the use of rhEPO to reduce top-up transfusions in neonates with red blood cell alloimmunization.
100 Clinical Results associated with Epoetin alfa biosimilar (United Biomedical)
Login to view more data
100 Translational Medicine associated with Epoetin alfa biosimilar (United Biomedical)
Login to view more data
100 Patents (Medical) associated with Epoetin alfa biosimilar (United Biomedical)
Login to view more data
100 Deals associated with Epoetin alfa biosimilar (United Biomedical)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Chronic Kidney Diseases | NDA/BLA | Taiwan Province | - | |
| Anemia of renal disease | Preclinical | - | 01 Mar 2016 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free